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Abstract
Introduction: Caffeine is the most common psychoactive drug in use around the world and is 
found at different concentrations in a variety of common food items. Clinically, a strong asso-
ciation between caffeine consumption and diseases of the vestibular system has been estab-
lished. Cervical vestibular-evoked myogenic potential (cVEMP) is an electrophysiological test 
that is used to assess the sacculocollic pathway by measuring changes in the vestialibulocollic 
UHÁH[
Aim: The present study aimed to evaluate the effect of an acute dose of caffeine on the 
YHVWLEXORFROOLFUHÁH[E\XVLQJF9(03
Method: A prospective experimental study was performed in which healthy volunteers were 
submitted to the test before and after the intake of 420 mg of caffeine. The following param-
eters were compared: p13 and n23 latencies and p13-n23 amplitude. 
Result:1RVWDWLVWLFDOO\VLJQLÀFDQWGLIIHUHQFHZDVIRXQGLQWKHWHVWUHVXOWVEHIRUHDQGDIWHU
caffeine use. 
Conclusion:7KHYHVWLEXORFROOLFUHÁH[LVQRWDOWHUHGE\FDIIHLQHLQWDNH
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier 
Editora Ltda. All rights reserved.
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O efeito da cafeína no potencial evocado miogênico vestibular cervical em indivíduos saudáveis
Resumo
Introdução: A cafeína é a droga psicoativa mais consumida no mundo e está contida, em dife-
rentes concentrações, em diversos alimentos consumidos no dia a dia. Clinicamente, nota-se 
um envolvimento importante do seu consumo com as doenças do sistema vestibular. O VEMP 
FHUYLFDOpXPH[DPHHOHWURÀVLROyJLFRTXHDYDOLDDYLDViFXORFyOLFDGHWHUPLQDQGRDOWHUDo}HV
QRUHÁH[RYHVWtEXORFyOLFR
Objetivo:2REMHWLYRGHVWHWUDEDOKRpDYDOLDUDLQWHUIHUrQFLDGRXVRDJXGRGHFDIHtQDQRUHÁH[R
YHVWtEXORFyOLFRDWUDYpVGRF9(03
Método:)RLUHDOL]DGRXPHVWXGRH[SHULPHQWDOSURVSHFWLYRQRTXDOYROXQWiULRVVDXGiYHLVVH
Please cite this article as: Sousa AMA, Suzuki FA. Effect of caffeine on cervical vestibular-evoked myogenic potential in healthy indivi-
duals. Braz J Otorhinolaryngol. 2014;80:226-30. 
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Introduction
Caffeine is the psychoactive drug most widely consumed 
worldwide.1,2 Like theophylline and theobromine, it is 
an alkaloid from the group called methylxanthines, dif-
fering from these substances by the presence of a third 
PHWK\OJURXS LGHQWLÀHGDVWULPHWK\O[DQWKLQH3 At 
different concentrations, caffeine is present in several 
substances consumed in daily life: coffee, green tea, cho-
colate, cola drinks, guarana, yerba mate, among others 
(Table 1).4,5
submeteram ao exame antes e depois do uso de 420 mg de cafeína, sendo comparados os se-
guintes parâmetros: latência de p13 e de n23 e interamplitude p13-n23. 
Resultado:$SyV D FRPSDUDomR GRV GDGRV QmR KRXYH GLIHUHQoD HVWDWLVWLFDPHQWH VLJQLÀFDQWH
HQWUHRVH[DPHVDQWHVHDSyVRXVRGDGURJD
Conclusão:1mRIRLREVHUYDGDLQÁXrQFLDGDFDIHtQDQRUHÁH[RYHVWtEXORFyOLFR
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Publicado por Elsevier 
Editora Ltda. Todos os direitos reservados.
Table 1 Main types of foods and beverages containing 
caffeine.
Item
(milliliters – mL)
Caffeine content
(milligrams - mg)
Tea (227 mL)
Weak 25
Medium 42
Strong 51
Coffee (227 mL)
Instant 45
Brewed 111
Cola drinks (330 mL) 35
Energetic drinks (240 mL) 80
Milk chocolate bar (9 g) 6
Dark chocolate bar (9 g) 20
Doses above 600 mg/day are considered excessive 
and abstinence symptoms can occur after abrupt with-
drawal, although these symptoms have been reported 
even with low-dose consumption (50-150 mg/day).10 
After ingestion of one cup of coffee (approximately 100 
mg of caffeine) there is an increase in caffeine levels 
of 1-2 mg/g in the blood. The lethal blood level is 80-
PJJWKDWZRXOGUHTXLUHDQLQWDNHRIDWOHDVWILYH
grams of caffeine, which suggests a fairly wide range of 
safety.7
Once ingested, caffeine is distributed homogeneous-
ly in the different organ systemsincluding the central 
nervous system (CNS), where it operates by blocking ad-
enosine receptors, mainly the type A1 and A2a.9 Adenos-
ine, in turn, is a neuromodulator that acts, along with 
other agents, to reduce  nerve conduction velocity.8
Thus caffeine, with its antagonistic effect on adenos-
ine receptors, increases this conduction velocity. Among 
other mechanisms, phosphodiesterase inhibition is at-
tributed to caffeine, as well as the sensitization of ry-
anodine receptors for calcium release and, finally, GABA 
receptor antagonism.3
Caffeine is metabolized by the liver and excreted by 
the kidneys with less than 5% being excreted in an un-
altered form.8
The cervical vestibular evoked myogenic potential 
(cVEMP) is a short-latency electrophysiological inhibito-
ry potential used for the assessment of the vestibular 
system through electromyography of the sternocleido-
mastoid muscle evoked by sound stimuli, bone vibra-
tion or electrical stimulation. This test has been used 
in practice to evaluate the vestibulocollic reflex (VCR) 
and assess the integrity of the sacculo-collic pathway: 
saccule, inferior vestibular nerve, vestibular nucleus, 
medial vestibulo-spinal pathway, nucleus and accessory 
nerves and sternocleidomastoid muscle.11-14
The cVEMP exhibits a biphasic waveform, of which 
the first peak is positive and called p13, and the second 
peak is negative, and called n23. Three main parame-
ters are evaluated: p13, n23and p13-n23 amplitude. The 
latter should be measured not as an absolute value, but 
as a relative value compared to the contralateral side 
or the ipsilateral side in different moments.15 This is 
because the absolute values of p13-n23 vary according 
to the degree of muscle contraction, to the conduction 
and placement of the electrodes and the to the intensity 
DQGIUHTXHQF\RIVWLPXOXVSUHVHQWDWLRQ11,16,17
The literature shows increased cVEMP amplitude 
after the administration of furosemide and glycerol in 
patients with endolymphatic hydrops.18-20 This is objec-
tively determined by the calculated change index (CI).
After its oral ingestion, the molecule is rapidly absorbed 
by the gastrointestinal tract, reaching peak plasma con-
centration in 15 to 60 minutes,6-8 with a half-life of 2.5 to 
10 hours.8 In moderate doses, caffeine promotes a sense 
of well-being, reduces fatigue, improves motor skills and 
increases alertness and attention.9 However, at higher dos-
es, the drug can cause anxiety, panic attacks, hallucina-
tions, irritability, and can have a negative action on motor 
FRQWURODQGTXDOLW\RIVOHHS0RGHUDWHFRQVXPSWLRQ
300 mg/day) in healthy individuals is not associated with 
VLJQLÀFDQWDGYHUVHHIIHFWV4
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The objective of the present study is to assess the 
actual effect of caffeine on the sacculo-collic pathway 
through cVEMP, measured at two different times.
Subjects and methods
Sample selection 
A total of 25 young healthy adult subjects were selected as 
a convenient sample. The volunteers underwent a detailed 
KLVWRU\DQGJHQHUDODQGVSHFLÀFSK\VLFDOH[DPLQDWLRQ7KH\
had abstained from caffeine for at least 24 hours prior to 
the assessment. 
The sample was categorized according to age and gen-
der and daily caffeine intake. The exclusion criteria were 
cochlear diseases; medications that interfere with the ves-
tibular system; migraine crises, hypertension, dyslipidemia, 
endocrine diseases including diabetes mellitus, hepatic, 
gastric or renal disorders and sleep disturbances.
Drug administration
Caffeine was administered in capsules, which give a more 
rapid and controlled peak effect compared to coffee and 
cola-derived drinks in the same concentration; the peak of 
drug action occurs in approximately 60 minutes.21 Two cap-
sules with 210 mg of pure caffeine were given to every indi-
vidual undergoing clinical study, for a total dose of 420 mg. 
7KLVGRVH LV VXIÀFLHQW WR UHDFKWKHSODVPDFRQFHQWUDWLRQV
necessary to block adenosine receptors, promoting the ex-
SHFWHGVWLPXODWLQJHIIHFWVEXWZLWKRXWFDXVLQJVLJQLÀFDQW
side effects.9
Test
The cVEMP was performed using a Nihon-Kohden evoked 
potential response unit, Neuropack MEB-5504K model, 
installed in an environment with electric and acoustic 
insulation. The tests were performed by placing ear-bud 
type earphones in each ear and three electrically isola-
ted surface electrodes, fixed with electrolytic conduc-
tion glue in the transition between the upper and middle 
thirds of the right and left sternocleidomastoid muscle 
(inverted electrodes - negative) and one inch below the 
sternal notch on the manubrium of the sternum (not in-
verted electrode - positive). The maximum impedance 
permitted for the measurement was five Kohms.
Each volunteer was placed in the supine position on a 
180-degree reclining chair and was asked to performed head 
ÁH[LRQDWDSSUR[LPDWHO\GXULQJWKHSUHVHQWDWLRQRIWKH
sound stimulus, so that the sternocleidomastoid muscle 
remained contracted at the moment of recording.
A narrow-band tone-burst stimulus was given at an 
intensity of 100 decibels sound pressure level at a fre-
TXHQF\ RI  +HUW] 7KH SUHVHQWDWLRQ UDWH ZDV ILYH
Hertz. Two binaural measurements were performed, 
with an interval of two minutes between them to allow 
the patient to rest; 200 stimuli were averaged in each of 
these measurements.
The electromyography of sternocleidomastoid mus-
cle was obtained using a low-pass filter of 1000 Hz and 
10 Hz high-pass, with artifact rejection, represented in 
a window of 50 milliseconds. Thus the biphasic complex 
response was obtained, of which the first positive de-
flection was called p13 and the first negative deflection 
was called n23.
Three main measurements were made in absolute val-
ues: latency for the p13 wave, latency for the n23 wave 
(both in milliseconds) and p13-n23 amplitude (in micro-
volts). After analysis of these data, p13 and n23 latencies 
were compared before and after drug ingestion. The for-
mula shown in Figure 1 was used for the comparison of the 
p13-n23 amplitude before and after caffeine ingestion; it 
is widely used in studies that compare cVEMP before and 
after the intake of other drugs such as furosemide and 
glycerol,15,19,20 since there is a significant individual 
variation in the absolute value of the p13-n23 ampli-
tude.
However, it was necessary to determine the normal 
range of this index. To do that we assumed that the right 
and left ears of each individual were symmetrical and 
used the formula shown in Figure 2 for the calculation 
of the asymmetry index (AI) in control tests, determin-
ing that the mean plus two standard deviations was the 
maximum value allowed as asymmetry.15,19,20 The values 
were described in module.
Figure 1 Change Index (CI).
Figure 2 Asymmetry index (AI).
Study design
This is an historical cross-sectional cohort study, approved 
by the institutional Research Ethics Committee, under the 
number 0127/11. All the 25 participants received explana-
tions regarding all procedures to be performed and signed 
the free and informed consent form.
The volunteers were instructed to abstain from caffeine 
for at least 24 hours prior to the test. 
Two tests were performed on each of the subjects with 
DPHDQLQWHUYDORIPLQXWHV$IWHUWKHÀUVWWHVWWKHLQ-
dividuals received two capsules containing pure caffeine 
PJFDSVXOHZLWKP/RIÀOWHUHGZDWHU WRKHOS
deglutition. 
Normal values of p13, n23, p13-n23 amplitude and AI 
were obtained from the tests prior to drug ingestion and 
these values were compared to those obtained in tests after 
FDIIHLQHLQJHVWLRQWRDVVHVVWKHGUXJLQÁXHQFHRQWKHHOHF-
trophysiological response capture.
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To prevent analysis bias, the examiner did not know 
whether an examination was performed before or after drug 
administration.
Statistical analysis
Descriptive data analysis was performed, as well as the non
-parametric comparison between groups before and after 
drug administration.
Numerical data are shown as mean and standard devia-
tion (SD) and categorical data as percentages. Wilcoxon test 
was used to compare the groups before and after caffeine 
DGPLQLVWUDWLRQ7KHOHYHORIVLJQLÀFDQFHZDVVHWDWS
Results
The sample consisted of 68% female and 32% male subjects. 
The mean age of the volunteers was 29 years, ranging from 
25 to 37 years. The mean daily caffeine intake was 148 mg, 
ranging from 0 to 500 mg.
A comparative analysis of data from the right and left 
ears at the tests before administration of caffeine, which 
included p13 and n23 latencies and p13-n23 amplitude, 
showed no statistical difference between the sides. Thus, 
we assumed that there is no difference between sides and 
the groups were joined and analyzed as a single group of 
50 ears. To determine the threshold value of the interpeak 
amplitude, we considered n = 25, as the AI is only possible 
between the sides. The normal values are shown in Table 2.
When applying the Wilcoxon test for paired samples, 
LWZDV REVHUYHG WKDW WKHUHZDV QR VWDWLVWLFDOO\ VLJQLÀFDQW
difference between the tests before and after the use of 
caffeine, with respect to the p13 and n23 latencies, as well 
as the p13-n23 amplitude (Table 3).
Table 2 Normality values.
Mean SD n
p13 13.41  1.27 50
n23 23.24 2.74 50
IA   14.20%    6.97% 25
Table 3 Comparison between tests.
     Pre  Post p
Mean    13.41     13.56
p13 SD    1.27     1.39 0.248
n 50 50
Mean 23.24 23.14
n23 SD   2.74   2.71 0.546
n 50 50
Mean 71.90 76.82
Amplitude 
p13n23
SD 47.85 48.22 0.170
n 50 50
It was observed that the AI considered normal for 
the test conditions was 28% (mean + 2SD). Thus, when 
comparing the Change Index (CI), it was observed that 
no ear had a higher index than the normal standard val-
ue of 28%.
Discussion
Caffeine is a neuromodulator widely used by the world’s 
population. It has been implicated in a number of effects, 
which mainly involve the CNS, through the inhibition of ade-
nosine receptors.
The data found in the literature and otoneurological 
clinical experience show adverse clinical effects from caf-
IHLQHZLWKVLJQLÀFDQWLPSURYHPHQWLQV\PSWRPDWLFSDWLHQWV
with a gradual reduction in consumption; sudden drug ces-
sation can lead to withdrawal symptoms.5,10 For example, 
in patients who are caffeine users and have a diagnosis of 
vestibular migraine, it has been suggested that caffeine dis-
continuation is essential for clinical improvement.22
&RQVLGHULQJWKLV LQIRUPDWLRQRQHZRXOGH[SHFWWRÀQG
some kind of alteration in patient examination after caf-
feine ingestion, since caffeine causes vestibular symptoms. 
However, by analyzing the data obtained when comparing 
the 50 ears before and after drug administration, no signif-
icant differences were found in latencies and amplitudes 
of the waves, with the CI remaining within normal limits. 

After ingestion of 300 mg of caffeine, there is an in-
crease of 30 micromoles of the drug in blood plasma,9 so 
the ingestion of 420 mg of the substance should increase 
the plasma level at least to that value. At these plasma lev-
els, caffeine acts primarily on adenosine receptors,23 hav-
LQJOLWWOHRUQRLQÁXHQFHRQFDOFLXPSKRVSKRGLHVWHUDVHDQG
GABA.9,24 Therefore, at the dose used, one should expect 
VRPH VLJQLÀFDQW DFWLRQRQDGHQRVLQH UHFHSWRUV7RREWDLQ
an effect on the other physiological mechanisms, one would 
need a much higher plasma drug level, which would exceed 
the toxic dose of caffeine. Therefore, we did not consider 
the possible effects on these mechanisms for purposes of 
the present study.
The distribution of adenosine receptors varies according 
to their type. The A1 receptors are located throughout the 
brain, but are mainly concentrated in the hippocampus, ce-
rebral cortex, cerebellum and hypothalamic nuclei. The A2a 
receptors are concentrated in the striatum, and its main 
role is attributed to dopamine modulation.8,25,26 The cVEMP 
is a short latency potential that evaluates the integrity of 
the sacculo-collic pathway, which includes the saccule, in-
ferior vestibular nerve, vestibular nucleus, vestibulospinal 
tract, nucleus and accessory nerve and sternocleidomastoid 
PXVFOHDQGLVDUHÁH[VWULFWO\LSVLODWHUDOWRWKHVWLPXOXV12 
Thus, there is no localization of adenosine receptors with 
the studied sacculo-colic pathway.
After the ingestion of 3 mg/kg of caffeine in humans, 
the auditory brainstem evoked potential showed a statis-
WLFDOO\VLJQLÀFDQWUHGXFWLRQLQODWHQFLHVRIZDYHV,9DQG9
and a tendency for a reduction in the amplitudes of waves 
,,,DQG,,,WKDWZDVQRWVWDWLVWLFDOO\VLJQLÀFDQW(YDOXDWLQJ
middle latency auditory potentials, after caffeine ingestion 
UHYHDOHGHYHQPRUHVLJQLÀFDQWUHVXOWV9 demonstrating that 
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DGHQRVLQHUHFHSWRUVKDYHDJUHDWHULQÁXHQFHDWWKHFHQWUDO
level than at the periphery.
The vestibular nuclei both receive and emit nerve im-
pulses to the central and peripheral organs. Thus, the ves-
tibular nuclei connect with the oculomotor nuclei, medial 
longitudinal fasciculus, medial and lateral vestibular spinal 
tract, cerebral cortex, cerebellar peduncle and the vestib-
ular commissural system, autonomic nervous system and 
the thalamus.27 As previously mentioned, the presence of 
adenosine receptors in these central vestibular pathways 
has been documented. Thus, we believe these numerous 
connections of the vestibular nuclei with the other central 
pathways could lead to the deleterious effects of caffeine 
in several peripheral vestibular pathways, even if the latter 
did not have adenosine receptors.
Although the administered dose of caffeine was enough 
to act on adenosine receptors, there were no alterations in 
any of the test parameters in the study model, which leads 
us to infer that these receptors are absent or show a re-
duced presence in the sacculo-collic pathway. That suggests 
WKDWWKHUHLVDQHJOLJLEOHLQÁXHQFHRIDGHQRVLQHUHFHSWRUV
on the sacculo-collic pathway and further studies are nec-
essary to clarify the distribution of these receptors in the 
peripheral vestibular pathways. In addition, the study sub-
jects had no diagnosed vestibular dysfunction, which does 
QRWUXOHRXWWKHSRVVLEOHRFFXUUHQFHRIFDIIHLQHLQÁXHQFHRQ
vestibular pathway disorders. 
+RZHYHUWKLVGRHVQRW LQYDOLGDWHWKHLQÁXHQFHRIFDI-
feine on the vestibular system, which consists of several 
other peripheral and central structures, as described.
Conclusion
:HFRQFOXGHWKDWWKHUHZDVQRVWDWLVWLFDOO\VLJQLÀFDQWGLI-
ference in cVEMP in young adults after ingestion of 420 mg 
RIFDIIHLQHLQWKHVWXGLHGPRGHOZKLFKVKRZVOLWWOHLQÁXHQ-
ce of caffeine on the examination.
&RQÁLFWVRILQWHUHVW
7KHDXWKRUVGHFODUHQRFRQÁLFWVRILQWHUHVW
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